Navigation Links
Johnson & Johnson Postpones Medical Devices & Diagnostics Review
Date:10/30/2012

NEW BRUNSWICK, N.J., Oct. 30, 2012  /PRNewswire/ -- Given the state of emergency in New Jersey due to Hurricane Sandy, Johnson & Johnson (NYSE: JNJ) announced that it will postpone the company's Medical Devices & Diagnostics business review for the investment community, which was scheduled for Thursday, Nov. 1st.  The company made the postponement decision to ensure the safety of its employees and expected attendees in the aftermath of the storm.  A new date for the business review will be scheduled for early 2013.

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
3. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
4. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
5. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
6. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
7. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
8. EFJohnson Announces Impact Partner Dealer Program
9. Johnson Health Tech Statement on Lance Armstrong
10. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
11. Johnson & Johnson Announces Plans to Establish Innovation Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Research and Markets has announced the addition ... - Forecast to 2025" report to their offering. ... Global Optogenetics Market is ... next decade to reach approximately $76.24 million by 2025. ... growing count of labs using optogentic techniques for neurosciences, quick growth ...
(Date:1/24/2017)... -- For today, Stock-Callers.com scans the following Biotechnology ... Biopharmaceuticals Inc. (NASDAQ: ALDR ), BioDelivery Sciences International ... EGLT ). These equities are part of the ... rd , 2017, with the NYSE Health Care Index dropping ... S&P 500 also were down 0.3% as a group. These ...
(Date:1/24/2017)... INTRODUCTION Injectable drug delivery systems have ... vials to prefilled syringes, auto-injectors, pen injectors and ... preferred devices for parenteral administration of drugs. Specifically, ... strongly over the past several years. A growing ... format for delivering drugs. The popularity of prefilled ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... ... the expansion of its Medication Counseling Centers to address market needs. To support ... MCC staff by more than 60 percent over the past 6 months. The ...
(Date:1/24/2017)... ... January 24, 2017 , ... In comments ... Research Institute (PCORI) for developing a data access and sharing policy. The nation’s ... data sharing plan as part of award applications, and earmarking specified amounts of ...
(Date:1/24/2017)... ... January 24, 2017 , ... The ... the Annual Enrollment Period (AEP) and the Open Enrollment Period (OEP). 2016 was ... coverage. Mainly, people are witnessing higher deductibles, rising premiums, and few choices with ...
(Date:1/24/2017)... ... January 24, 2017 , ... PeroxyChem Food and Beverage Safety ... (PACE), at the International Production and Processing Expo (IPPE) in Atlanta, Georgia from ... technology that is used in poultry processing facilities to provide constant, real-time data ...
(Date:1/24/2017)... ... January 24, 2017 , ... Manzo Pharmaceuticals, LLC., announced that ... Trademark by the United States Patent and Trademark Office. The purpose of ... consumers into thinking that other products are similar to the patented Lacto-Freedom Probiotic. ...
Breaking Medicine News(10 mins):